These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 27607340

  • 1. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I, Mammen AL.
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [Abstract] [Full Text] [Related]

  • 2. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 3. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.
    Curr Rheumatol Rep; 2018 Aug 03; 20(9):56. PubMed ID: 30074107
    [Abstract] [Full Text] [Related]

  • 4. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS, Silva VGD, Vieira TF, Delgado PO, Corazini R, Feder D, Fonseca FLA.
    Medicine (Baltimore); 2018 Aug 03; 97(35):e11858. PubMed ID: 30170376
    [Abstract] [Full Text] [Related]

  • 5. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y, Benveniste O, Stenzel W, Boyer O.
    Nat Rev Rheumatol; 2020 Dec 03; 16(12):689-701. PubMed ID: 33093664
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA.
    Arthritis Rheum; 2011 Mar 03; 63(3):713-21. PubMed ID: 21360500
    [Abstract] [Full Text] [Related]

  • 7. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G, Antonini G, Garibaldi M.
    Autoimmun Rev; 2022 Feb 03; 21(2):102993. PubMed ID: 34798316
    [Abstract] [Full Text] [Related]

  • 8. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I, Casal-Dominguez M, Mammen AL.
    Curr Rheumatol Rep; 2018 Mar 26; 20(4):21. PubMed ID: 29582188
    [Abstract] [Full Text] [Related]

  • 9. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.
    Bergua C, Chiavelli H, Allenbach Y, Arouche-Delaperche L, Arnoult C, Bourdenet G, Jean L, Zoubairi R, Guerout N, Mahler M, Benveniste O, Drouot L, Boyer O.
    Ann Rheum Dis; 2019 Jan 26; 78(1):131-139. PubMed ID: 30309969
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
    Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL.
    Arthritis Care Res (Hoboken); 2017 Feb 26; 69(2):263-270. PubMed ID: 27111848
    [Abstract] [Full Text] [Related]

  • 11. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct 26; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

  • 12. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A.
    Joint Bone Spine; 2014 Jan 26; 81(1):79-82. PubMed ID: 23953224
    [Abstract] [Full Text] [Related]

  • 13. [Immune-Mediated Necrotizing Myopathy].
    Uruha A.
    Brain Nerve; 2024 May 26; 76(5):646-654. PubMed ID: 38741508
    [Abstract] [Full Text] [Related]

  • 14. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.
    Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W.
    Neurology; 2018 Feb 06; 90(6):e507-e517. PubMed ID: 29330311
    [Abstract] [Full Text] [Related]

  • 15. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
    Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O.
    Ann Neurol; 2017 Apr 06; 81(4):538-548. PubMed ID: 28224701
    [Abstract] [Full Text] [Related]

  • 16. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.
    Medicine (Baltimore); 2015 Jan 06; 94(4):e416. PubMed ID: 25634171
    [Abstract] [Full Text] [Related]

  • 17. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y, Benveniste O.
    Curr Opin Rheumatol; 2018 Nov 06; 30(6):655-663. PubMed ID: 30239349
    [Abstract] [Full Text] [Related]

  • 18. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.
    Ann Rheum Dis; 2017 Apr 06; 76(4):681-687. PubMed ID: 27651398
    [Abstract] [Full Text] [Related]

  • 19. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y.
    Immunol Res; 2017 Feb 06; 65(1):276-281. PubMed ID: 27618830
    [Abstract] [Full Text] [Related]

  • 20. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P, Christopher-Stine L.
    Curr Rheumatol Rep; 2015 Dec 06; 17(12):72. PubMed ID: 26515574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.